• By ICR Secretariat
  • Posted Thursday, July 21, 2022

Roche’s combination breast cancer treatment delivers positive results

https://www.pharmatimes.com/news/roches_combination_breast_cancer_treatment_delivers_positive_results_1452295

Roche, the Breast International Group, Institut Jules Bordet Clinical Trials Support Unit and Frontier Science Foundation have announced updated data from the phase 3 APHINITY study into HER2-positive early breast cancer.